300832 ShenZhen New Industries Biomedical Engineering
- 77.04
- -0.79-1.02%
ShenZhen New Industries Biomedical Engineering News
New industry (300832.SZ): Shareholders and directors agree to reduce their holdings by no more than 483,400 shares in total
Gelonghui, May 13 | New Industry (300832.SZ) announced that the company recently received a “Notice Letter on the Share Reduction Plan” issued by Ms. Xu Dinghong, a shareholder and director of the company who holds more than 5% of the company's shares, and Ms. Liu Haiyan, senior management of the company, and Ms. Zhang Lei. Xu Dinghong, Liu Haiyan, and Zhang Lei held 103,360 shares, 1,139,700 shares, and 3,341,500 shares of the company's total share capital respectively (accounting for 0.0132%, 01451%, and 0.4253% of the company's total share capital, respectively), and are scheduled for 15 trading days from the date of the announcement of the reduction plan
Express News | 56 stocks were traded in bulk, with Jiusheng Electric leading the discount rate of 19.82%
Express News | National Data Administration: It is actively working with the Ministry of Industry and Information Technology, the Health and Health Commission and other departments to conduct systematic research on pilot programs in the fields of industrial manufacturin
Express News | The research team of the National Development and Reform Commission visited Tongshi Optoelectronics to inspect the low-altitude economic development situation
New Industries (300832.SZ) plans to pay $10 for every 10 shares in 2023, excluding interest on May 15
New Industry (300832.SZ) announced that the company plans to pay 10.00 for every 10 shares to all shareholders in 2023...
Express News | In 2024, Beijing announced a total of 60 key work points to comprehensively optimize the business environment
New industry (300832): excellent performance, increasing the share of overseas medium and large machines, rapid growth in reagents
Event: On April 11, 2024, the company released its 2023 annual report. In 2023, the company achieved operating income of 3,930 billion yuan, an increase of 28.97% over the previous year; achieved net profit of 1,654 billion yuan to mother
Express News | JAC and others invest in the establishment of a new intelligent technology company
New industry (300832): Performance is in line with expectations, high speed machine installation+reagent release drive increase in profit level
Incident: The company released its report for the first quarter of 2024, achieving operating income of 1,021 million yuan (YoY +16.62%), net profit attributable to mother of 426 million yuan (YoY +20.04%), deducting net profit of non-return to mother3.
Express News | The scale of the Xinchuang industry in Tianjin Binhai New Area is expected to reach 500 billion yuan in 2027
Express News | Zhao Li, Deputy Director of the Development Planning Department of the National Energy Administration: The country's energy consumption continues to grow, and energy supply and demand are generally stable
New industry (300832): Mainframe share increased, overseas growth maintained rapid growth
Guide to this report: Domestic market installed capacity is improving month-on-month, mainframe and assembly line promotion continues to expand large-scale medical terminal customers, and overseas is expected to maintain a rapid growth trend through regional management models and localized operations. Maintain an increase in holdings rating. Investment Essentials: Maintaining
Express News | State Assets Administration Commission: It is necessary to flexibly use methods such as mergers and acquisitions, listing financing, industrial collaboration, and joint research to develop new industries
New industry (300832): 1Q24 results are in line with expectations, gross margin increased year-on-year
1Q24 results are in line with our expectations. The company announced 1Q24 results: revenue of 1,021 million yuan, up 16.6% year on year; net profit to mother of 426 million yuan, up 20.0% year on year; net profit without return to mother of 3.99 percent
New Industries (300832) 2024 Quarterly Report Review: Continued High Growth Overseas Reagent Business Share Increased
Matters: The company released its quarterly report for 2014, with operating income of 1,021 million yuan (+16.62%), net profit of 426 million yuan (+20.04%) to mother, deducting non-net profit of 399 million yuan (+25.49%)
Express News | Geely Remote New Energy Commercial Vehicle Battle New Industry Series Project Settles in Dalian
New industries (300832): First-quarter results are in line with expectations, maintaining good overseas growth
Event: The company released its report for the first quarter of 2024. In the first quarter of 2024, it achieved operating income of 1,021 million yuan (+16.62%) and net profit to mother of 426 million yuan (+20.04%), which is not net
Nomura Adjusts Shenzhen New Industries Biomedical Engineering's Price Target to 93.36 Yuan From 98.15 Yuan, Keeps at Buy
04:55 AM EDT, 04/26/2024 (MT Newswires) -- Nomura Adjusts Shenzhen New Industries Biomedical Engineering's Price Target to 93.36 Yuan From 98.15 Yuan, Keeps at Buy
Express News | New industry: Net profit from mother in the first quarter was 426 million yuan, up 20.04% year on year
New industry (300832): rapid 1Q profit growth and continued improvement in profitability
1Q24 net profit grew rapidly year on year, and profitability continued to improve. The company's 1Q24 operating income/net profit attributable to mother/net profit after deduction of 10.21/4.26/399 million yuan, +16.6% /+20 over the same period last year.
Analysis
Price Target
No Data
